TīmeklisRaj Tummala,1 Gabriel Abreu,2 Lilia Pineda,1 M Alex Michaels,1 Rubana N Kalyani,1 Richard A Furie,3 Eric F Morand4 To cite: Tummala R, Abreu G, Pineda L, et al. Safety profile ... AstraZeneca, Gaithersburg, Maryland, USA 2BioPharmaceuticals R&D, … Tīmeklis12 BioPharmaceuticals R&D, AstraZeneca US, Gaithersburg, Maryland, USA [email protected]. PMID: 35580976 PMCID: PMC9213793 DOI: 10.1136/annrheumdis-2024-221847 Abstract Objectives: In the anifrolumab systemic …
Full article: Safety and tolerability of anifrolumab, a monoclonal ...
TīmeklisRaj Tummala,1 Tomas Rouse,2 Anna Berglind,2 Linda Santiago3 To cite: Tummala R, Rouse T, Berglind A, et al. Safety, tolerability ... Dr Raj ummala; T Raj. ummala@T astrazeneca. com Clinical trials and drug discovery AbstrAct Objectiveso compare … TīmeklisRaj Tummala is the Director AT Astrazeneca at Astrazeneca based in United States. Get Raj Tummalas Contact Info. Contact Information. Business Email ****@astrazeneca.com. Get Email Address. Direct Phone +1 20***** Get Phone … farm income and expense ledger
Efficacy of anifrolumab across organ domains in patients with …
TīmeklisEdward R Hammond,1 Raj Tummala,2 Anna Berglind,3 Farhat Syed,4 Xia Wang,5 Barnabas Desta,6 Henk Nab7 To cite: Hammond ER, Tummala R, Berglind A, et al. Study protocol for the international Systemic Lupus Erythematosus Prospective Observational Cohort Study (SPOCS): understanding lupus and the role of type I … TīmeklisRaj Tummala,1 Tomas Rouse,2 Anna Berglind,2 Linda Santiago3 To cite: Tummala R, Rouse T, Berglind A, et al. Safety, tolerability ... Dr Raj ummala; T Raj. ummala@T astrazeneca. com Clinical trials and drug discovery AbstrAct Objectiveso compare the pharmacokinetics (PK), safety T TīmeklisThere are 5 professionals named "Raj Tummala", who use LinkedIn to exchange information, ideas, and opportunities. ... Executive Medical Director at AstraZeneca Gaithersburg, MD. AstraZeneca, +3 more farm income at risk